Welcome to Springer Nature – a leading global research, health and educational publisher

Springer Nature is a leading global research, health and educational publisher, providing quality content to our communities through a range of innovative platforms, products and services. Every day, around the globe, our imprints, books, journals and resources reach millions of people - helping researchers, students, teachers and healthcare professionals to discover, learn and achieve more. Through our family of brands, we aim to serve and support the research, education and healthcare professional communities by putting them at the heart of all we do, delivering the highest possible standards in content and technology, and helping shape the future of publishing for their benefit and for society overall.
  • What we do matters – sharing trusted knowledge for over 180 years to help accelerate solutions to the world’s urgent challenges
  • We operate in growing and resilient markets with tailwinds from Open Access and AI
  • We hold leading positions in highly attractive segments thanks to our clear and proven growth strategy and trusted brands
  • We are a leader in technology set to benefit from tech opportunities that will improve the service we offer to our communities and so drive performance and growth
  • We can rely on our experienced management team, our 9000 highly talented colleagues around the world and an extensive specialist external research network
  • We have a proven financial track record of steady growth and cash flow generation

Financial Highlights

Investment Highlights

Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Share Price

Latest Documents

At the moment there isn’t any publication available for this section.

Contacts

Thomas Geisselhart

Corporate Finance and Investor Relations
+49 30 827 87 5415

Cornelius Rahn

Communications Director, DACH
+49 151 1563 7515
Contact for media inquiries

Some of our trusted brands